A power morcellator manufacturer has threatened to sue a Boston man whose campaign to end this type of procedure has resulted in a barrage of media attention, and raised awareness about its possible association with the spread of uterine sarcoma and other cancers.

According to an August 27th report from The Cancer Letter, the Karl Storz Group has demanded that Dr. Hooman Noorchasm stop “defaming” its Rotocut device, which was used in the fibroid removal surgery that preceded his wife’s uterine cancer diagnosis last year. Since then, the Boston doctor started a petition that seeks the U.S. government to ban uterine morcellation surgeries in the U.S. That Change.org petition included 75,480 supporters, as of August 29th.

“We will no longer tolerate unfounded and unproven allegations such as the ones contained in your previous emails and we will hold you responsible,” Karl Storz said in its letter to Noorchasm. “Should we get to know further public statements from you that our device and/or management would be responsible for your wife’s and/or other women’s uterine cancer, and/or aggravation of their cancerous situations, we would not hesitate to take appropriate legal actions to protect our good name and our rights.”

U.S. Hospitals Veer Away from Power Morcellator Surgery

According to The Cancer Letter, Brigham and Women’s Hospital in Massachusetts, as well as several other top U.S. facilities, have curbed their power morcellator use in laparoscopic hysterectomy and fibroid removal surgeries.

Although Karl Storz solely blames Noorchasm for his supposed bad-mouthing of the Rotocut, the company fails to mention the U.S. Food and Drug Administration (FDA)’s own questioning of power morcellator safety.

In April 2014, the federal agency issued a power morcellator warning about their possible association with the dissemination of cancer cells. Officials estimated that 1 in every 350 women having fibroids removed may have undiagnosed uterine cancer that not be detected until after fibroids are removed and biopsied. By then, cancer cells may have already spread outside the uterus and into the peritoneal cavity, making it more difficult to treat.

The Johnson & Johnson subsidiary, Ethicon Inc. announced in July that it would be issuing a “worldwide market withdrawal” of its power morcellators, after deciding a few months earlier to stop selling them until the FDA could fully assess their safety.

Filing a Power Morcellator Lawsuit

If you or a loved one were diagnosed with uterine sarcoma or another cancer after a fibroid removal surgery that utilized a power morcellator, call our Firm today to find out if you have a case. Call us now at (877) 779-1414.

Published August 29, 2014 by